JP Morgan Chase
TWST icon

JP Morgan Chase’s Twist Bioscience TWST Stock Holding History

JP Morgan Chase’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,200
Closed -$207K – 7686
2024
Q2 		$207K Buy
+4,200
New +$171K ﹤0.01% 5151

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase's TWST Position: Q2 2026 in Review

JP Morgan Chase reduced its Twist Bioscience (TWST) stake by 0.25% in Q2 2026, selling an estimated $33.8K and leaving 205,248 shares worth $20.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

JP Morgan Chase first reported a position in TWST in Q4 2018 and has held it in 31 quarters since. The position peaked at $256M in Q4 2020. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • JP Morgan Chase held 205,248 shares of Twist Bioscience worth $20.5M as of Q2 2026.
  • JP Morgan Chase sold 519 Twist Bioscience shares in Q2 2026, an estimated $33.8K.
  • Twist Bioscience made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2197 holding.
  • JP Morgan Chase first reported a position in Twist Bioscience in Q4 2018 and has held it in 31 quarters since.
  • JP Morgan Chase's Twist Bioscience position peaked at $256M in Q4 2020.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.